Risk factors for postoperative Clostridium difficile infection after radical cystectomy for bladder cancer: a NSQIP database analysis.


Journal

The Canadian journal of urology
ISSN: 1195-9479
Titre abrégé: Can J Urol
Pays: Canada
ID NLM: 9515842

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 12 6 2022
pubmed: 13 6 2022
medline: 15 6 2022
Statut: ppublish

Résumé

Patients undergoing cystectomy for bladder cancer are at an increased risk for Clostridium difficile infection (CDI) due to prolonged antibiotics and underlying comorbidities. We aim to evaluate CDI risk factors in cystectomy patients. Utilizing National Surgical Quality Improvement Program (NSQIP), patients undergoing cystectomy with diagnosis of bladder cancer between 2015-2017 were included. Baseline demographics including age, sex, comorbidities, and preoperative labs were collected. Univariate and multivariable logistic regression were used to evaluate risk factors for and complications of CDI during the index hospitalization. There were a total of 6,432 patients included in the analysis, with 6,242 (96%) and 190 (4%) in the non-CDI vs. CDI groups, respectively. Patients with a diagnosis of postoperative CDI were more likely to be female [4.09% vs. 2.71%, p = 0.001] and have lower preoperative albumin [3.78 g/dL (0.52) vs. 3.92 g/dL (0.48), p = 0.003]. Patients with a history of female sex (OR 1.46, p = 0.03), neobladder (OR 1.57, p = 0.01), and low preoperative albumin (OR 1.45, p = 0.04) were at the highest risk for development of CDI postoperatively. Patients with a diagnosis of CDI were more likely to experience readmission within 30 days (31.1% vs. 19.2%, p < 0.001). Utilizing the NSQIP database, we identified predictors for development of CDI in cystectomy patients. Female sex, continent diversion, and low preoperative albumin all significantly increased the rate of CDI. While our findings are retrospective, they are compelling enough to warrant further prospective investigation.

Identifiants

pubmed: 35691039

Substances chimiques

Albumins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11170-11174

Auteurs

Megan Prunty (M)

Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
University Hospitals Cleveland Medical Center, Urology Institute, Cleveland, Ohio, USA.

Laura Bukavina (L)

Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
University Hospitals Cleveland Medical Center, Urology Institute, Cleveland, Ohio, USA.

Amr Mahran (A)

University Hospitals Cleveland Medical Center, Urology Institute, Cleveland, Ohio, USA.

Kirtishri Mishra (K)

Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
University Hospitals Cleveland Medical Center, Urology Institute, Cleveland, Ohio, USA.

Mostafa Abdelrazek (M)

South Valley University School of Medicine, Egypt.

Sarah Markt (S)

Case Western Reserve University School of Medicine, Department of Population and Quantitative Health Sciences, Cleveland, Ohio, USA.

Lee Ponsky (L)

University Hospitals Cleveland Medical Center, Urology Institute, Cleveland, Ohio, USA.

Adam C Calaway (AC)

University Hospitals Cleveland Medical Center, Urology Institute, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH